Human papillomaviruses modulate microRNA 145 expression to directly control genome amplification

Journal of Virology

Volumn 87, Issue 10, 2013, Pages 6037-6043

  Gunasekharan, Vignesh ^a   Laimins, Laimonis A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN E1; GLYCOPROTEIN E2; KRUPPEL LIKE FACTOR 4; MICRORNA 145; MICRORNA 146A;

ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; DOWN REGULATION; GENE AMPLIFICATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; LIFE CYCLE STAGE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION; VIRUS CELL INTERACTION; WART VIRUS;

GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; MICRORNAS; PAPILLOMAVIRIDAE; VIRUS REPLICATION;

EID: 84877355736     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00153-13     Document Type: Article

References (40)

1. Moody CA, Laimins LA. 2010. Human papillomavirus oncoproteins: pathways to transformation. Nat. Rev. Cancer 10:550 -560.
2. Munger K, Howley PM. 2002. Human papillomavirus immortalization and transformation functions. Virus Res. 89:213-228.
3. Wang HK, Duffy AA, Broker TR, Chow LT. 2009. Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes Dev. 23:181-194.
4. Gunasekharan V, Hache G, Laimins L. 2012. Differentiation-dependent changes in levels of C/EBPbeta repressors and activators regulate human papillomavirus type 31 late gene expression. J. Virol. 86:5393-5398.
5. Lin HR, Ganem D. 2011. Viral microRNA target allows insight into the role of translation in governing microRNA target accessibility. Proc. Natl. Acad. Sci. U. S. A. 108:5148 -5153.
6. Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
7. Uhlmann S, Mannsperger H, Zhang JD, Horvat EA, Schmidt C, Kublbeck M, Henjes F, Ward A, Tschulena U, Zweig K, Korf U, Wiemann S, Sahin O. 2012. Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer. Mol. Syst. Biol. 8:570.
8. Gokey NG, Srinivasan R, Lopez-Anido C, Krueger C, Svaren J. 2012. Developmental regulation of microRNA expression in Schwann cells. Mol. Cell. Biol. 32:558-568.
9. Lee RC, Feinbaum RL, Ambros V. 1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843- 854.
10. Zhao Y, Srivastava D. 2007. A developmental view of microRNA function. Trends Biochem. Sci. 32:189 -197.
11. Bentwich I. 2005. A postulated role for microRNA in cellular differentiation. FASEB J. 19:875- 879.
12. Guo L, Zhao RC, Wu Y. 2011. The role of microRNAs in self-renewal and differentiation of mesenchymal stem cells. Exp. Hematol. 39:608-616.
13. Le MT, Xie H, Zhou B, Chia PH, Rizk P, Um M, Udolph G, Yang H, Lim B, Lodish HF. 2009. MicroRNA-125b promotes neuronal differentiation in human cells by repressing multiple targets. Mol. Cell. Biol. 29: 5290-5305.
14. Schoolmeesters A, Eklund T, Leake D, Vermeulen A, Smith Q, Force Aldred S, Fedorov Y. 2009. Functional profiling reveals critical role for miRNA in differentiation of human mesenchymal stem cells. PLoS One 4:e5605.
15. Hamfjord J, Stangeland AM, Hughes T, Skrede ML, Tveit KM, Ikdahl T, Kure EH. 2012. Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing. PLoS One 7:e34150.
16. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet- Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. 2005. MicroRNA expression profiles classify human cancers. Nature 435:834-838.
17. Stahlhut Espinosa CE, Slack FJ. 2006. The role of microRNAs in cancer. Yale J. Biol. Med. 79:131-140.
18. Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C, GrasserFA, van Dyk LF, Ho CK, Shuman S, Chien M, Russo JJ, Ju J, Randall G, Lindenbach BD, Rice CM, Simon V, Ho DD, Zavolan M, Tuschl T. 2005. Identification of microRNAs of the herpesvirus family. Nat. Methods 2:269 -276.
19. Cai X, Li G, Laimins LA, Cullen BR. 2006. Human papillomavirus genotype 31 does not express detectable microRNA levels during latent or productive virus replication. J. Virol. 80:10890 -10893.
20. McKenna DJ, McDade SS, Patel D, McCance DJ. 2010. MicroRNA 203 expression in keratinocytes is dependent on regulation of p53 levels by E6. J. Virol. 84:10644 -10652.
21. Melar-New M, Laimins LA. 2010. Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins. J. Virol. 84:5212-5221.
22. Martinez I, Gardiner AS, Board KF, Monzon FA, Edwards RP, Khan SA. 2008. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 27:2575-2582.
23. Greco D, Kivi N, Qian K, Leivonen SK, Auvinen P, Auvinen E. 2011. Human papillomavirus 16 E5 modulates the expression of host microRNAs. PLoS One 6:e21646.
24. Lajer CB, Garnaes E, Friis-Hansen L, Norrild B, Therkildsen MH, Glud M, Rossing M, Lajer H, Svane D, Skotte L, Specht L, Buchwald C, Nielsen FC. 2012. The role of miRNAs in human papilloma virus (HPV)- associated cancers: bridging between HPV-related head and neck cancer and cervical cancer. Br. J. Cancer 106:1526 -1534.
25. Zheng ZM, Wang X. 2011. Regulation of cellular miRNA expression by human papillomaviruses. Biochim. Biophys. Acta 1809:668-677.
26. Hong S, Mehta KP, Laimins LA. 2011. Suppression of STAT-1 expression by human papillomaviruses is necessary for differentiationdependent genome amplification and plasmid maintenance. J. Virol. 85: 9486-9494.
27. Moody CA, Laimins LA. 2009. Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation. PLoS Pathog. 5:e1000605.
28. Mighty KK, Laimins LA. 2011. p63 is necessary for the activation of human papillomavirus late viral functions upon epithelial differentiation. J. Virol. 85:8863- 8869.
29. Sen GL, Boxer LD, Webster DE, Bussat RT, Qu K, Zarnegar BJ, Johnston D, Siprashvili Z, Khavari PA. 2012. ZNF750 is a p63 target gene that induces KLF4 to drive terminal epidermal differentiation. Dev. Cell 22:669-677.
30. Xu N, Papagiannakopoulos T, Pan G, Thomson JA, Kosik KS. 2009. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 137:647- 658.
31. Davis-Dusenbery BN, Chan MC, Reno KE, Weisman AS, Layne MD, Lagna G, Hata A. 2011. Down-regulation of Kruppel-like factor-4 (KLF4) by microRNA-143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-beta and bone morphogenetic protein 4. J. Biol. Chem. 286:28097-28110.
32. Takaoka Y, Shimizu Y, Hasegawa H, Ouchi Y, Qiao S, Nagahara M, Ichihara M, Lee JD, Adachi K, Hamaguchi M, Iwamoto T. 2012. Forced expression of miR-143 represses ERK5/c-Myc and p68/p72 signaling in concert with miR-145 in gut tumors of Apc(Min) mice. PLoS One 7:e42137.
33. Xin M, Small EM, Sutherland LB, Qi X, McAnally J, Plato CF, Richardson JA, Bassel-Duby R, Olson EN. 2009. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev. 23:2166 -2178.
34. Giarre M, Caldeira S, Malanchi I, Ciccolini F, Leao MJ, Tommasino M. 2001. Induction of pRb degradation by the human papillomavirus type 16 E7 protein is essential to efficiently overcome p16INK4a-imposed G1 cell cycle arrest. J. Virol. 75:4705-4712.
35. Spitkovsky D, Hehner SP, Hofmann TG, Moller A, Schmitz ML. 2002. The human papillomavirus oncoprotein E7 attenuates NF-kappa B activation by targeting the Ikappa B kinase complex. J. Biol. Chem. 277: 25576-25582.
36. Vandermark ER, Deluca KA, Gardner CR, Marker DF, Schreiner CN, Strickland DA, Wilton KM, Mondal S, Woodworth CD. 2012. Human papillomavirus type 16 E6 and E7 proteins alter NF-kB in cultured cervical epithelial cells and inhibition of NF-kB promotes cell growth and immortalization. Virology 425:53- 60.
37. Bernat A, Avvakumov N, Mymryk JS, Banks L. 2003. Interaction between the HPV E7 oncoprotein and the transcriptional coactivator p300. Oncogene 22:7871-7881.
38. Cho WC, Chow AS, Au JS. 2009. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. Eur. J. Cancer 45:2197- 2206.
39. Sachdeva M, Zhu S, Wu F, Wu H, Walia V, Kumar S, Elble R, Watabe K, Mo YY. 2009. p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc. Natl. Acad. Sci. U. S. A. 106:3207-3212.
40. Zhang J, Guo H, Zhang H, Wang H, Qian G, Fan X, Hoffman AR, Hu JF, Ge S. 2011. Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene. Cancer 117:86 -95.